If possible, it’s a good point. Generex had a very similar issue with Alpha in 2017. Gnbt issued a convertible note to Alpha in exchange for over 600k. $500k went to Emmaus. Once that Letter of Intent with Emmaus was terminated, Alpha’s attorney notified that the event triggered a default. They demanded payment due. Gnbt paid it back, but later- costing the company another $75k in a late fee. That’s a lot of money to just give as a late fee.
Generex does sign on to these conditions, and maybe it’s better that Fletcher was replaced if he had anything to do with Generex making conditions, that if aren’t met trigger a default, that appear overly optimistic. Jmho
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links